Page last updated: 2024-10-29

amrinone and Pancytopenia

amrinone has been researched along with Pancytopenia in 1 studies

Amrinone: A positive inotropic cardiotonic (CARDIOTONIC AGENTS) with vasodilator properties, phosphodiesterase 3 inhibitory activity, and the ability to stimulate calcium ion influx into the cardiac cell.
amrinone : A 3,4'-bipyridine substituted at positions 5 and 6 by an amino group and a keto function respectively. A pyridine phosphodiesterase 3 inhibitor, it is a drug that may improve the prognosis in patients with congestive heart failure.

Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.

Research Excerpts

ExcerptRelevanceReference
"The incidence of amrinone-induced thrombocytopenia has been reported to be 2."7.68Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990)
"The incidence of amrinone-induced thrombocytopenia has been reported to be 2."3.68Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone. ( Burnette, PK; Manny, RP; Mattingly, PM; Weston, MW, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mattingly, PM1
Burnette, PK1
Weston, MW1
Manny, RP1

Other Studies

1 other study available for amrinone and Pancytopenia

ArticleYear
Pancytopenia secondary to short-term, high-dose intravenous infusion of amrinone.
    DICP : the annals of pharmacotherapy, 1990, Volume: 24, Issue:12

    Topics: Amrinone; Bone Marrow; Dopamine; Heart Failure; Humans; Hypotension; Infusions, Intravenous; Male; M

1990